Cargando…
Biomarkers in the clinical management of patients with atrial fibrillation and heart failure
Atrial fibrillation (AF) and heart failure (HF) are two cardiovascular diseases with an increasing prevalence worldwide. These conditions share common pathophysiologiesand frequently co-exit. In fact, the occurrence of either condition can ‘cause’ the development of the other, creating a new patient...
Autores principales: | Koniari, Ioanna, Artopoulou, Eleni, Velissaris, Dimitrios, Ainslie, Mark, Mplani, Virginia, Karavasili, Georgia, Kounis, Nicholas, Tsigkas, Grigorios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648548/ https://www.ncbi.nlm.nih.gov/pubmed/34908928 http://dx.doi.org/10.11909/j.issn.1671-5411.2021.11.010 |
Ejemplares similares
-
Effect of atrial fibrillation on cognitive function in heart failure patients
por: Ktenopoulos, Nikolaos, et al.
Publicado: (2021) -
Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management
por: Koniari, Ioanna, et al.
Publicado: (2021) -
Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022) -
Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients
por: Koniari, Ioanna, et al.
Publicado: (2022) -
Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
por: Koniari, Ioanna, et al.
Publicado: (2023)